Effectiveness of HPV Hybrid Capture in Primary Screening of Cervical Lesions On Routine Public Health Care

Authors

  • Tânia Maria CW Veras
  • Francisco Holanda Junior
  • Maria Zélia Lins
  • José Túlio Gomes
  • Francisco de Oliveira Lima
  • João Batista Silva
  • Adhemar Longatto-Filho
  • Adauto Castekfi
  • Luiz Gonzaga Pinheiro

Keywords:

uterine cervix neoplasia, oncology cytology, human papillomavirus, hybrid capture

Abstract

Introduction: high risk human papillomavirus (hrHPV) is responsible for almost 100% of the uterine cervical lesions. Objective: to compare hrHPV Hybrid Capture (CH) and conventional Papanicoalou cytology (CC) in the screening performance of uterine cancerous and precancerous lesions. Methods: cross-sectional study assessing sensitivity, specificity and predictive values of both CC and CH to detect cervical lesions. Cervical sampling for CC was initially collected followed by endo and ectocervical sampling for CH, using the Digene kit. Thereafter, patients underwent colposcopy and cervical biopsy if needed. In the presence of an altered colposcopy, histopathology results were the gold-standard. Otherwise, the normal colposcopy was considered. Cervical disease was defined as any intraepithelial lesion (low grade +). Patients with unsatisfactory colposcopy were excluded. Results: a total of 1658 women were included. CC tumed out negative in 1594 (96.6%) women and abnormal cells found in 56 (3.4%): 1.6% (26/56) ASCUS, 0.1% (2/56) AGUS, 1.5% (24/56) CIN I, 0.2% (4/56) CIN II/III. There was no invasive câncer. CH was positive in 19% (315/1658) of the cases. Both CC and CH were negative in 1313 (79.6%) women; 303 (18.4%) were positive in one of the two tests, and 34 (2%)
were positive for both. 1602 women with negative CC, 281 (17.5%) showed positive CH. In 22 (1.3%) women, CH was negative and CC positive; however, only two patients showed LSIL. On the other hand, 315 cases with positive CH, 281 (89.2%) had negative CC, with 8.5% (24/281) of women with histologically confirmed lesion. CH sensitivity (71.7%) was significantly higher than CC (30.2%) [p < 0.001], but CC showed higher specificity than CH (97.5% and 82.7% respectively; p < 0.001). Conclusion: the adoption of new screening technologies, such as hrHPV HC, taking advantage of the current knowledge on virai etiology and pathogenesis of cervical câncer, could lead to important reduction in mortality caused by this type of câncer.

Downloads

Download data is not yet available.

Author Biographies

Tânia Maria CW Veras

Diretora do Instituto de Prevenção de Câncer do Ceará, Secretária de Saúde do Ceará.

Francisco Holanda Junior

Coordenador da Coordenadoria de Apoio à Atenção à Saúde, Secretária de Saúde do do Ceará. 

Maria Zélia Lins

Médica ginecologista do município de Pedra Branca.

José Túlio Gomes

Médico ginecologista do município de Crato.

Francisco de Oliveira Lima

Médico ginecologista do município de Tianguá.

João Batista Silva

Médico ginecologista do município de Redenção.

Adhemar Longatto-Filho

Pesquisador Científico, Divisão de Patologia do Instituto Adolfo Lutz, São Paulo. Professor Adjunto, UNIFESP, São Paulo.

Adauto Castekfi

Professor Adjunto da Universidade Federal do Ceará.

Luiz Gonzaga Pinheiro

Professor Adjunto da Universidade Federal do Ceará.

Published

2006-03-18

How to Cite

1.
Veras TMC, Holanda Junior F, Lins MZ, Gomes JT, Lima F de O, Silva JB, et al. Effectiveness of HPV Hybrid Capture in Primary Screening of Cervical Lesions On Routine Public Health Care. DST [Internet]. 2006 Mar. 18 [cited 2024 Nov. 21];18(1):23-9. Available from: https://bdst.emnuvens.com.br/revista/article/view/606

Issue

Section

Original Article